Related Experiment Video

Updated: Jun 17, 2026

3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer
09:24

3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer

Published on: September 13, 2018

Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancer

Margaret A Knowles1, Fiona M Platt, Rebecca L Ross

  • 1Cancer Research UK Clinical Centre, Leeds Institute of Molecular Medicine, St James's University Hospital, Beckett Street, Leeds LS9 7TF, UK. M.A.Knowles@leeds.ac.uk

Cancer Metastasis Reviews
|December 17, 2009
PubMed

Insights

The phosphatidylinositol 3-kinase (PI3K) pathway is crucial in cellular functions and cancer. Targeting this complex pathway requires detailed molecular insights into individual tumors, especially in bladder cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Signal Transduction

Background:

  • The phosphatidylinositol 3-kinase (PI3K) pathway regulates fundamental cellular processes.
  • Aberrant PI3K pathway activation is implicated in various cancers, making its components like AKT, PI3K, and mTOR key therapeutic targets.
  • Developing effective inhibitors for this pathway is challenging due to its complex regulation and multiple activation mechanisms.

Purpose of the Study:

  • To investigate alterations in PI3K pathway components within bladder cancer.
  • To correlate these genetic alterations with tumor phenotype and clinical behavior.
  • To understand the non-canonical functions of PI3K pathway proteins in bladder tumors.

Main Methods:

  • Analysis of genetic alterations in PI3K pathway genes (PIK3CA, PTEN, AKT1, TSC1) in bladder cancer samples.
  • Correlation of identified alterations with clinical data and tumor characteristics.

Main Results:

  • Alterations in PIK3CA, PTEN, AKT1, and TSC1 were identified in bladder cancer.
  • Specific alterations were significantly associated with tumor phenotype and clinical behavior.
  • Some bladder tumors exhibit co-existing alterations in multiple PI3K pathway genes.

Conclusions:

  • Detailed molecular profiling of individual tumors is essential for effective PI3K pathway inhibition.
  • PI3K pathway alterations are relevant to bladder cancer progression and clinical outcomes.
  • The presence of multiple genetic alterations suggests potential non-canonical roles for PI3K pathway proteins in bladder cancer.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...